AstraZeneca approached Gilead about potential merger – Bloomberg News

(Reuters) – AstraZeneca Plc (AZN.L) has approached rival drugmaker Gilead Sciences Inc (GILD.O) about a potential merger, Bloomberg News reported on Sunday, citing people familiar with the matter. AstraZeneca contacted Gilead last month and it did not provide terms of any transaction, the report bloom.bg/3h2GU9e added. The two companies were not immediately available for comment.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s